Baird reiterates Neutral rating on BioMarin stock at $65
In
Investing.comBy Investing.com10/27/2026, 8:34:59 AM
EXECUTIVE SUMMARY
Baird reiterates Neutral rating on BioMarin stock at $65....
Key Takeaways
- Baird reiterates Neutral rating on BioMarin stock at $65.
Read Complete Original Article
Published originally on Investing.com
OTHER MEDIA SOURCES COVERING THIS STORY
2 Publishers ReportingRelated News
finance9 minutes ago
French yields edge higher as Moody’s relief fades; Israeli election in focus
French yields edge higher as Moody’s relief fades; Israeli election in focus Investing.com Australia
finance9 minutes ago
PU Prime Puts Trader Education and LATAM Outlook in Focus at FX Expo Medellín 2026
PU Prime Puts Trader Education and LATAM Outlook in Focus at FX Expo Medellín 2026 المتداول العربي
finance12 minutes ago
Why is Swedish Orphan Biovitrum stock rallying today? By Investing.com
Why is Swedish Orphan Biovitrum stock rallying today? By Investing.com Investing.com Australia
finance12 minutes ago
Why is Standard Chartered stock sliding today? By Investing.com
Why is Standard Chartered stock sliding today? By Investing.com Investing.com Australia
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!